Whole exome sequencing, which is valuable in detecting disease-causing mutations in humans, is now being offered by Craig Venter to clients for a low cost. Through the collaboration of Venter's company with a South-African insurance firm, clients may now avail of this typically high-cost service at a much cheaper price.